Glaxosmithkline reported GBP17.04B in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US USD 37.35B 193M
AstraZeneca AZN:LN USD 23.68B 3.47B
Aurora Cannabis Inc ACB:CN CAD 286.06M 49.58M
Canopy Growth Corp WEED:CN CAD 1.12B 239.18M
Catalent CTLT:US USD 4.1B 73M
Drreddys Laboratories RDY:US INR 1.46B 338M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Glaxosmithkline GSK:US GBP 17.04B 2.29B
Horizon Pharma HZNP:US USD 2.55B 1.85M
Novartis NOVN:VX USD 21.78B 547M
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Perrigo Ordinary Shares PRGO:US USD 4.08B 8.6M
Prestige Brands PBH:US USD 1.43B 14.95M
Roche Holding ROG:VX 22.37B 6.29B
Takeda 4502:JP JPY 3.91T 253.53B
Teva Pharmaceutical TEVA:IT USD 18.5B 1.87B
Valeant Pharmaceuticals VRX:CN USD 20.8B 860M
Zoetis ZTS:US USD 5.21B 11M